Aortic Root Dilation and Genotype Associations in Phelan-McDermid Syndrome

Jake Gluckman1,2, Tess Levy1,2, Kate Friedman1,2

  • 1Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Insights

Phelan-McDermid syndrome (PMS) patients with larger chromosome 22 deletions have a higher risk of aortic root dilation (ARD). This finding helps identify individuals with PMS at increased risk for this cardiovascular abnormality.

Area of Science:

  • Genetics
  • Cardiology
  • Developmental Biology

Background:

  • Phelan-McDermid syndrome (PMS) is a rare genetic disorder linked to SHANK3 gene loss.
  • Cardiovascular abnormalities in PMS are understudied, particularly aortic root dilation (ARD).

Purpose of the Study:

  • To determine the prevalence of ARD in individuals with PMS.
  • To investigate the association between genetic variation (deletion size) and ARD risk in PMS.

Main Methods:

  • Analysis of echocardiographic and genetic data from 59 PMS participants in a multisite observational study.
  • Comparison of ARD incidence based on the start coordinates of chromosome 22 deletions (hg19).

Main Results:

  • 14% of participants (8/59) exhibited ARD.
  • ARD was significantly associated with larger chromosome 22 deletions (p=0.047).
  • Individuals with ARD had significantly more deleted genes on chromosome 22 (p=0.013).

Conclusions:

  • Larger deletions on chromosome 22 are linked to an increased risk of ARD in Phelan-McDermid syndrome.
  • These findings can help identify PMS patients at higher risk for ARD, enabling targeted monitoring and management.